<DOC>
	<DOCNO>NCT01964833</DOCNO>
	<brief_summary>The relationship diabetes mellitus ( DM ) periodontal disease bidirectional . DM predispose modify factor periodontitis , , turn , worsen glycemic control increase protein find acute phase inflammation . The gold standard treatment periodontal disease oral hygiene orientation , scale plan . Moreover , systemic antibiotic therapy may employ case . In effort minimize prescription antibiotic , photodynamic therapy ( PDT ) study antimicrobial technique demonstrate promising result . The aim propose study determine whether PDT complement periodontal therapy ( PT ) helpful metabolic control individual type 2 diabetes reduction acute phase inflammatory marker . The patient randomize use proper software program two group : 1 ) PT + placebo PDT 2 ) PT + active PDT . All patient first examine specialist , follow PT perform two healthcare professional . At end session , PDT ( active sham ) administer fourth healthcare professional . The following PDT parameter : diode laser ( 660 nm ) ; power output = 110 mW ; exposure time = 90 second per point ( 9 J/point ) ; energy density = 22 J/cm2 . The photosensitizer methylene blue ( 50 µg/mL ) . The patient re-evaluated 15 , 30 , 90 180 day treatment . Serological exam complete blood count , fast glucose , glycated hemoglobin crevicular fluid exam screen tumor necrosis factor alpha , interleukin 1 , interleukin 6 , osteocalcin , osteoprotegerin/RANKL perform evaluation . At baseline 180 day periapical radiograph perform evaluate alveolar bone crest level . The data statistically evaluate use appropriate test .</brief_summary>
	<brief_title>PDT Periodontal Treatment DMT2 Patients</brief_title>
	<detailed_description>Randomization patient different group perform appropriate software program . Only lead researcher access randomization list . Allocation two group carry block four . The patient send Operator A periodontal exam . Without knowledge result exam , patient treat Operators B C periodontal treatment , involve oral hygiene instruction well supra-gingival sub-gingival scale plan four session . At end session , patient send Operator D , administer either placebo active PDT base content seal envelope . Thus , patient operator charge periodontal exam blind PDT protocol ( double-blind study ) . Fasting blood sugar glycated hemoglobin exam perform baseline well 15 , 30 , 90 180 day completion treatment . All exam carry laboratory affiliate university . The clinical periodontal exam perform single examiner specialize periodontics , evaluate six region tooth 15-mm probe ( North Carolina model , Hu-Friedy , Chicago , IL , USA ) . The following aspect record : plaque index , bleed upon probe , probe depth , gingival recession attachment loss ( Armitage , 2004 ) . Evaluations carry performed baseline ( prior initial treatment ) well 15 , 30 , 90 180 day completion treatment . Patients receive periodontal treatment photodynamic therapy ( active sham depend allocation ) . Crevicular fluid collect previously define site probe depth equal great 4 mm receive treatment . Collection perform relative isolation use cotton roll follow removal supra-gingival plaque periodontal curettes air dry five second . Absorbent paper strip ( PerioPaper , ProFlow Inc. , Amityville , NY , USA ) individually insert site 30 second ( Rudin et al. , 1970 ) . The collection perform single researcher . The volume crevicular fluid sample measure use Periotron 8000 micro-moisture meter ( Oraflow Inc. , NY , USA ) . The sample place duly identify sterile plastic microtubes , temporarily store dry ice subsequently store freezer -80 ºC</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Compensated type 2 diabetes mellitus adequate control base criterion Brazilian Society Diabetes ( SBD , 2012 ) ; 2 . Chronic periodontitis ( AAP , 2001 ) ; 3 . Presence least 15 teeth least four teeth bleed upon probe probe depth great 4 mm ; 4 . Aged 18 year old ; 5 . Under follow endocrinologist . 1 . Uncompensated diabetes , base SBD criterion ; 2 . Smoking habit 12 month prior treatment ; 3 . Anemia ; 4 . Active cancer ; 5 . Current pregnancy ; 6 . History antibiotic therapy previous six month ; 7 . History antiinflammatory therapy previous three month ; 8 . Clotting disorder ( use anticoagulant , presence liver disease , thrombocytopenia immunosuppression ) ; 9 . Currently undergo orthodontic treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>clinical trial</keyword>
	<keyword>DMT2</keyword>
	<keyword>periodontitis</keyword>
	<keyword>PDT</keyword>
</DOC>